Researcher Profiles

Return to member profile

Helmut Zarbl, PhD

Publications since 2011

Fang, M. Z. Ohman-Strickland, P. Kelly-McNeil, K. Kipen, H. Crabtree, B. F. Lew, J. P. Zarbl, H. Sleep interruption associated with house staff work schedules alters circadian gene expression. Sleep Med, 16:1388-1394, . (PMID: 26498241, PMCID: PMC4621493)

Fang, M. Guo, W. R. Park, Y. Kang, H. G. Zarbl, H. Enhancement of NAD+-dependent SIRT1 deacetylase activity by methylselenocysteine resets the circadian clock in carcinogen-treated mammary epithelial cells. Oncotarget, In process, . (PMID: 26544624)

Green, A. L. Hossain, M. M. Tee, S. C. Zarbl, H. Guo, G. L. Richardson, J. R. Epigenetic Regulation of Dopamine Transporter mRNA Expression in Human Neuroblastoma Cells. Neurochem Res, In process, . (PMID: 25963949)

Mukherjee, D. Royce, S. G. Alexander, J. A. Buckley, B. Isukapalli, S. S. Bandera, E. V. Zarbl, H. Georgopoulos, P. G. Physiologically-based toxicokinetic modeling of zearalenone and its metabolites: application to the jersey girl study. PLoS One, 9:e113632, . (PMID: 25474635)

Ren, X. Graham, J. C. Jing, L. Mikheev, A. M. Gao, Y. Lew, J. P. Xie, H. Kim, A. S. Shang, X. Friedman, C. Vail, G. Fang, M. Z. Bromberg, Y. Zarbl, H. Mapping of Mcs30, a New Mammary Carcinoma Susceptibility Quantitative Trait Locus (QTL30) on Rat Chromosome 12: Identification of Fry as a Candidate Mcs Gene. PLoS One, 8:e70930, . (PMID: 24023717, PMCID: PMC3759375)

Graham, J. C. Zarbl, H. Use of cell-SELEX to generate DNA aptamers as molecular probes of HPV-associated cervical cancer cells. PLoS One, 7:e36103, . (PMID: 22536456, PMCID: PMC3335032)

Bandera, E. V. Chandran, U. Buckley, B. Lin, Y. Isukapalli, S. Marshall, I. King, M. Zarbl, H. Urinary mycoestrogens, body size and breast development in New Jersey girls. Sci Total Environ, 409:5221-5227, . (PMID: 21975003, PMCID: PMC3312601)

Kisby, G. E. Fry, R. C. Lasarev, M. R. Bammler, T. K. Beyer, R. P. Churchwell, M. Doerge, D. R. Meira, L. B. Palmer, V. S. Ramos-Crawford, A. L. Ren, X. Sullivan, R. C. Kavanagh, T. J. Samson, L. D. Zarbl, H. Spencer, P. S. The cycad genotoxin MAM modulates brain cellular pathways involved in neurodegenerative disease and cancer in a DNA damage-linked manner. PLoS One, 6:e20911, . (PMID: 21731631, PMCID: PMC3121718)